Lung Cancer and Aging: Improving Well-being for Older Adults With Lung Cancer
Lung Cancer and Aging (LuCA): Intervention Development for Addressing Aging-specific Concerns in Older Adults With Lung Cancer
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- 60 Years and older
- Sex
- All sexes
- Healthy volunteers
- Accepted
- Compensation
- Not stated
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
- Time periods mentioned: 5 weeks
- Procedures mentioned: Interviews, Questionnaires
Only what the study's summary and detailed description on ClinicalTrials.gov say. Time periods may describe the whole study or a part of it — ask the study team what applies to you.
Show the study's own words
- "In the first phase of this study, participants (12 patients with lung cancer, 6 caregivers, 12 providers) will be asked to participate in two individual interviews (each 30-45 minutes in length) via teleconference."
- "During the first interview, participants will be asked to provide feedback on the current version of the assessment and behavioral intervention."
- "After the research team has made changes to the materials, participants will be invited to complete a second interview to provide feedback on the updated materials."
- "The investigators will then conduct interviews with lung cancer patients (N=12), provider stakeholders (N=12), and caregivers (N=6) in order to obtain feedback on the proposed assessment and intervention."
- "Caregiver participants will be either a) caregivers for lung cancer patients participating in interviews for this study, or b) caregivers for other patients with lung cancer."
- "Each interview will be 30-45 minutes in length."
- Compensation
- Not stated
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
In plain language
This study is developing a short check-in and a skills program to help older adults with lung cancer manage concerns about aging. The current phase is for adults age 60 or older who are getting lung cancer treatment at Duke University Health System. It will check how well the program works for patients and measure changes in depression, anxiety, pain, and trouble breathing.
The purpose of this study is to develop a brief assessment and need-based behavioral intervention for addressing aging-specific concerns in older adults with lung cancer. The long-term goals of this research include identifying the unique concerns of these patients, providing patients with behavioral skills to address their symptom management needs, and enhancing patient engagement with healthcare specialties targeting aging-specific concerns. In the first phase of this study, participants (12 patients with lung cancer, 6 caregivers, 12 providers) will be asked to participate in two individual interviews (each 30-45 minutes in length) via teleconference. During the first interview, participants will be asked to provide feedback on the current version of the assessment and behavioral intervention. Participants will be asked to describe strengths and weaknesses of the materials, topics to add or remove, and any other suggested changes. After the research team has made changes to the materials, participants will be invited to complete a second interview to provide feedback on the updated materials. In the second phase of the study, 16 older adults with lung cancer will complete the revised assessment and participate in the behavioral intervention, in order to a) evaluate the feasibility and acceptability of the program and b) measure change in depression, anxiety, pain, and dyspnea. \*\* Phase I of the study was previously factored into the record via the overall status and start date, but the record has been revised as of 08-2026 and is now only a reflection of Phase II.
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Who can join
- Have lung cancer.
- Are age 60 or older.
- Are getting active treatment at Duke University Health System.
- Can speak and read English.
- Can give informed consent, meaning they understand the study and agree to join.
Who can't join
- Have problems with vision, hearing, memory, or thinking, or a serious mental illness that makes it hard to take part.
Simplified for readability. The official criteria below are what the study team uses.
Official eligibility criteria
Inclusion Criteria for Patient Participants: * Lung cancer diagnosis * 60 years of age or older * Receiving active treatment at Duke University Health System * Able to speak/read English and provide informed consent Exclusion Criteria: * Visual or hearing impairment, cognitive impairment, or severe mental illness interfering with participation
Study sites (1)
NC
- Duke University Health System · Durham, NC 27705Nicole A Arrato, PhD · Study contact · 919-668-8660 · nicole.arrato@duke.eduRebecca A Shelby, PhD · Principal investigatorMore trials in Durham